Compass Therapeutics (CMPX) Shares Issued (2020 - 2026)
Compass Therapeutics (CMPX) posted Shares Issued of $8.2 million for Q1 2026, down 50.05% sequentially from $16.4 million in Q4 2025, and up 10.69% YoY from $7.4 million in Q1 2025.
Compass Therapeutics (CMPX) Shares Issued (2020 - 2026) Analysis & Trends
Compass Therapeutics has reported Shares Issued for 7 years, with the latest figure at $8.2 million in Q1 2026.
- Quarterly Shares Issued rose 10.69% year-over-year to $8.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.2 million (up 10.69% YoY) and the FY2025 annual result came in at $16.4 million, up 16.29% from the prior year.
- Shares Issued declined to $8.2 million in Q1 2026 per CMPX's latest filing, from $16.4 million in the prior quarter.
- Over five years, Shares Issued peaked at $17.2 million in Q3 2025 and troughed at $2182.0 in Q2 2022.
- A 5-year average of $8.4 million and a median of $7.9 million in 2023 frame the typical range for Shares Issued.
- The widest YoY moves for Shares Issued: up 148066.82% in 2023, down 36.07% in 2023.
- Over 5 years, Shares Issued stood at $5.4 million in 2022, then jumped by 46.45% to $7.9 million in 2023, then soared by 78.54% to $14.1 million in 2024, then advanced by 16.29% to $16.4 million in 2025, then slumped by 50.05% to $8.2 million in 2026.
- According to Business Quant data, Shares Issued over the past three periods registered $8.2 million, $16.4 million, and $17.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Compass Therapeutics | 405.20 Mn | 405.20 Mn | - | 23.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.65 Mn |
| Jun 30, 2026 | 23.65 Mn |
| Mar 31, 2026 | 8.17 Mn |
| Mar 31, 2026 | 8.17 Mn |
| Dec 31, 2025 | 16.35 Mn |
| Dec 31, 2025 | 16.35 Mn |
| Sep 30, 2025 | 17.16 Mn |
| Sep 30, 2025 | 17.16 Mn |
| Jun 30, 2025 | 8.34 Mn |
| Jun 30, 2025 | 8.34 Mn |
| Mar 31, 2025 | 7.38 Mn |
| Mar 31, 2025 | 7.38 Mn |
| Dec 31, 2024 | 14.06 Mn |
| Dec 31, 2024 | 14.06 Mn |
| Sep 30, 2024 | 13.63 Mn |
| Sep 30, 2024 | 13.63 Mn |
| Jun 30, 2024 | 11.33 Mn |
| Jun 30, 2024 | 11.33 Mn |
| Mar 31, 2024 | 4.45 Mn |
| Mar 31, 2024 | 4.45 Mn |